Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
The antimetastatic effect of the CD1d-binding glycolipid, α-galactosylceramide (α-GalCer), is mediated by NK1.1+T (NKT) cells; however, the mechanisms behind this process are poorly defined. Although it has been shown to involve NK cells and interferon-γ (IFN-γ) production, the way these factors collaborate to mediate effective tumor rejection and the importance of other factors characteristic of NKT cell and NK cell activation are unknown. Using gene-targeted mice and antibody treatments, the critical need for interleukin 12 (IL-12), IFN-γ, and NK cells has been shown in the antimetastatic activity of α-GalCer in the lungs and the liver. By contrast, in lung and liver metastasis models, cytotoxic molecules expressed by NK cells and NKT cells (perforin, Fas ligand, and tumor necrosis factor-related apoptosis-inducing ligand) and an NKT cell-secreted cytokine, IL-4, were not necessary for the antitumor activity of α-GalCer. Like IL-12, IL-18 was required for optimal serum IFN-γ induction and control of lung metastases by α-GalCer. IL-18 was unnecessary for α-GalCer–related suppression of liver metastases. Most importantly, after adoptive transfer of α-GalCer–reactive NKT cells or NK cells into NKT cell-deficient, IFN-γ–deficient, or RAG-1–deficient mice, it was demonstrated that the sequential production of IFN-γ by NKT cells and NK cells was absolutely required to reconstitute the antimetastatic activity of α-GalCer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
Bendelac, A., Rivera, M. N., Park, S.-H., & Roark, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.535 · Cited by 1,326
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses
Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., & Gately, M. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80413-6 · Cited by 989
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80543-9 · Cited by 911
Self-citationTracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887
NKT cells: facts, functions and fallacies
Godfrey, D. I., Hammond, K. J. L., Poulton, L. D., Smyth, M. J., & Baxter, A. G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01735-7 · Cited by 858
Self-citationCarnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
Yoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Self-citationMig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 779
NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S.-I., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1121 · Cited by 626
Self-citationSadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., & Locksley, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.115 · Cited by 620
Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing Mice
Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E., & Fukushima, H. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00012a018 · Cited by 599
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S., & Van Kaer, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80290-3 · Cited by 595
In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers
Benlagha, K., Weiss, A., Beavis, A., Teyton, L., & Bendelac, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1895 · Cited by 556
Smyth, M. J., Cretney, E., Takeda, K., Wiltrout, R. H., Sedger, L. M., Kayagaki, N., Yagita, H., & Okumura, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.661 · Cited by 512
Self-citationKawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
Hammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., & Baxter, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1047 · Cited by 474
Self-citationRüegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P., & Lejeune, F. J. (1998) · Nature Medicine · doi:10.1038/nm0498-408 · Cited by 450
Fowlkes, B. J., Kruisbeek, A. M., Ton-That, H., Weston, M. A., Coligan, J. E., Schwartz, R. H., & Pardoll, D. M. (1987) · Nature · doi:10.1038/329251a0 · Cited by 397
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · PubMed · Cited by 381
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379
Self-citationNK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
Self-citationFas-mediated cytotoxicity by freshly isolated natural killer cells.
Arase, H., Arase, N., & Saito, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1235 · Cited by 362
KRN7000, a novel immunomodulator, and its antitumor activities.
Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H., & Koezuka, Y. (1995) · PubMed · Cited by 361
Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Kaer, L. V. (1999) · PubMed · Cited by 358
Sonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.
MacDonald, H. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.633 · Cited by 345
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3271 · Cited by 334
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
Eberl, G., & MacDonald, H. R. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<985::aid-immu985>3.0.co;2-e · Cited by 326
Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Van Kaer, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2373 · Cited by 311
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
Smyth, M. J., Taniguchi, M., & Street, S. E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2665 · Cited by 301
Self-citationBurdin, N., Brossay, L., & Kronenberg, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06<2014::aid-immu2014>3.0.co;2-g · Cited by 301
Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., & Scalzo, A. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6658 · Cited by 295
Self-citationNKT cells are phenotypically and functionally diverse
Hammond, K. J. L., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J., van Driel, I. R., Scollay, R., Baxter, A. G., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3768::aid-immu3768>3.0.co;2-g · Cited by 262
Self-citationSonoda, K.-H., Faunce, D. E., Taniguchi, M., Exley, M., Balk, S., & Stein-Streilein, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.42 · Cited by 240
Körner, H., Riminton, D. S., Strickland, D. H., Lemckert, F. A., Pollard, J. D., & Sedgwick, J. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1585 · Cited by 238
Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., Kawano, T., et al. (2000) · International Immunology · doi:10.1093/intimm/12.7.987 · Cited by 224
Self-citationNKT cells and tumor immunity—a double-edged sword
Smyth, M. J., & Godfrey, D. I. (2000) · Nature Immunology · doi:10.1038/82698 · Cited by 209
Self-citationContribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12
Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.5.1612 · Cited by 201
IL-18 Augments Perforin-Dependent Cytotoxicity of Liver NK-T Cells
Dao, T., Mehal, W. Z., & Crispe, I. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2217 · Cited by 201
Hayakawa, Y., Takeda, K., Yagita, H., Van Kaer, L., Saiki, I., & Okumura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6012 · Cited by 195
Self-citationNakagawa, R., Motoki, K., Ueno, H., Iijima, R., Nakamura, H. K., Kobayashi, E., Shimosaka, A., & Koezuka, Y. (1998) · PubMed · Cited by 194
Hayakawa, Y., Takeda, K., Yagita∥, H., Kakuta, S., Iwakura, Y., Kaer, L. V., Saiki, I., & Okumura, K. (2001) · PubMed · Cited by 184
Self-citationPien, G. C., Satoskar, A. R., Takeda, K., Akira, S., & Biron, C. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4787 · Cited by 184
Self-citationLeite-de-Moraes, M. C., Hameg, A., Arnould, A., Machavoine, F., Koezuka, Y., Schneider, E., Herbelin, A., & Dy, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5871 · Cited by 177
Takeda, K., Seki, S., Ogasawara, K., Anzai, R., Hashimoto, W., Sugiura, K., Takahashi, M., Satoh, M., & Kumagai, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3366 · Cited by 170
Self-citationInvolvement of decidual Vα14 NKT cells in abortion
Ito, K., Karasawa, M., Kawano, T., Akasaka, T., Koseki, H., Akutsu, Y., Kondo, E., Sekiya, S., Sekikawa, K., Harada, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.740 · Cited by 169
Cui, J., Watanabe, N., Kawano, T., Yamashita, M., Kamata, T., Shimizu, C., Kimura, M. Y., Shimizu, E., Koike, J., Koseki, H., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.783 · Cited by 167
Nieda, M., Nicol, A., Koezuka, Y., Kikuchi, A., Lapteva, N., Tanaka, Y., Tokunaga, K., Suzuki, K., Kayagaki, N., Yagita, H., et al. (2001) · Blood · doi:10.1182/blood.v97.7.2067 · Cited by 166
Self-citationCD4+ Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice
Ikehara, Y., Yasunami, Y., Kodama, S., Takanobu, M. A. K. I., Nakano, M., Nakayama, T., Taniguchi, M., & Ikeda, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8922 · Cited by 164
Hayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., Van Kaer, L., Saiki, I., & Okumura, K. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1720::aid-immu1720>3.0.co;2-u · Cited by 161
Self-citationα-Galactosylceramide Induces Early B-Cell Activation through IL-4 Production by NKT Cells
Kitamura, H., Ohta, A., Sekimoto, M., Sato, M., Iwakabe, K., Nakui, M., Yahata, T., Meng, H., Koda, T., Nishimura, S., et al. (2000) · Cellular Immunology · doi:10.1006/cimm.1999.1602 · Cited by 155
Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
Brossay, L., Naidenko, O. V., Burdin, N., Matsuda, J. L., Sakai, T., & Kronenberg, M. (1998) · PubMed · Cited by 149
Brossay, L., Naidenko, O. V., Burdin, N., Matsuda, J. L., Sakai, T., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5124 · Cited by 137
Leite‐de‐Moraes, M., Hameg, A., Pacilio, M., Koezuka, Y., Taniguchi, M., Kaer, L. V., Schneider, E., Dy, M., & Herbelin, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.945 · Cited by 136
Lipid antigen presentation in the immune system; lessons learned from CD 1 d knockout mice
Hong, S., Scherer, D. C., Singh, N., Mendiratta, S. K., Serizawa, I., Koezuka, Y., & Kaer, L. V. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01304.x · Cited by 130
Koseki, H., Imai, K., Nakayama, F., Sado, T., Moriwaki, K., & Taniguchi, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5248 · Cited by 119
Fas/Fas Ligand Interactions Promote Activation-Induced Cell Death of NK T Lymphocytes
Leite‐de‐Moraes, M., Herbelin, A., Gouarin, C., Koezuka, Y., Schneider, E., & Dy, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4367 · Cited by 116
CD1-mediated immune responses to glycolipids
Burdin, N., & Kronenberg, M. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80052-1 · Cited by 94
Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
Takeda, K., Hayakawa, Y., Atsuta, M., Hong, S., Kaer, L. V., Kobayashi, K., Ito, M., Yagita∥, H., & Okumura, K. (2000) · International Immunology · doi:10.1093/intimm/12.6.909 · Cited by 90
Self-citationGee, M. S., Koch, C. J., Evans, S. M., Jenkins, W. T., Pletcher, C. H., Moore, J. S., Koblish, H. K., Lee, J. J., Lord, E. M., Trinchieri, G., et al. (1999) · PubMed · Cited by 75
Fuji, N., Ueda, Y., Fujiwara, H., Toh, T., Yoshimura, T., & Yamagishi, H. (2000) · PubMed · Cited by 66
Brossay, L., Burdin, N., Tangri, S., & Kronenbers, M. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01193.x · Cited by 51
Hameg, A., Apostolou, I., Leite‐de‐Moraes, M., Gombert, J., Cordier, C., Koezuka, Y., Bach, J., & Herbelin, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4917 · Cited by 48
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
Cited by
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
Kronenberg, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115742 · Cited by 1,029
Going both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
Self-citationTargeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
New aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Self-citation
Metadata
- Authors
- Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H., & Godfrey, D. I.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-02-15
- Volume
- 99
- Issue
- 4
- Pages
- 1259-1266
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2144821901
- Cited by
- 392
- References
- 70
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.